Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

TEMPUS PHOENIX HNSCC STUDY: A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck Squamous Cell Carcinoma (HNSCC)

NCT06163534 is registered in ClinicalTrials.gov with Tempus AI as lead sponsor.

NCT NCT06163534
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06163534 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
TEMPUS PHOENIX HNSCC STUDY: A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck Squamous Cell Carcinoma (HNSCC)
Lead sponsor
Tempus AI
Phase
Observational
Overall status
Recruiting
Start date
August 1, 2024
Completion date
March 1, 2028
Enrollment
500 (estimated)
Sites
32

Conditions

As the registry lists them; a condition with its own page is linked.

head and neck squamous cell carcinoma